Denise Scots Knight | Chief Executive Officer
Mereo Biopharma

Denise is CEO, a board member and co-founder of Mereo. Denise has over 25 years’ experience in the biopharmaceutical industry in R&D management and venture capital. She was in R&D management at Amersham and Fisons and a senior executive at Scientific Generics before joining Rothschild Asset Management as an investment manager. In 1999 she joined Nomura and was a Managing Director leading the life science investments in biotechnology companies. She led the Phase4 Partners MBO from Nomura in 2010. Denise had served on many US and European private and public boards. She is currently a board member of Elanco Animal Health Inc. Denise has a PhD and BSc (Hons) from Birmingham University and was a Fulbright scholar at UC Berkeley.